反应详情

温度

110 °C

A suspension of 375 mg (0.63 mmol) of ethyl 5-{[2-(2-{[4-(5-chloro-1,3-benzoxazol-2-yl)benzyl]-oxy}-5-fluorophenyl)ethyl]amino}-5,6,7,8-tetrahydroquinoline-2-carboxylate (Enantiomer 2, Example 117A), 272 mg (0.94 mmol) of methyl 4-(2-iodoethyl)benzoate and 99 mg (0.94 mmol) of anhydrous sodium carbonate in 10 ml of dry acetonitrile was stirred overnight at a bath temperature of 110° C. A further 272 mg of methyl 4-(2-iodoethyl)benzoate and 99 mg of sodium carbonate were then added, and the mixture was once more heated under reflux overnight. Another 272 mg of methyl 4-(2-iodoethyl)benzoate and 99 mg of sodium carbonate were then added, and the mixture was again heated under reflux overnight. After cooling of the reaction mixture, ethyl acetate and water were added, the organic phase was separated off and the aqueous phase was extracted three more times with ethyl acetate. The combined organic phases were dried over magnesium sulphate, filtered and evaporated to dryness. The residue obtained was purified chromatographically on silica gel (mobile phase: petroleum ether/ethyl acetate 4:1→2:1). This gave 324 mg (0.42 mmol, 68% of theory) of the target compound.

1. temperaturethe mixture was once more heated
2. temperatureunder reflux overnight
3. temperaturethe mixture was again heated
4. temperatureunder reflux overnight
5. additionwere added
6. customthe organic phase was separated off
7. extractionthe aqueous phase was extracted three more times with ethyl acetate
8. dry with materialThe combined organic phases were dried over magnesium sulphate
9. filtrationfiltered
10. customevaporated to dryness
11. customThe residue obtained
12. customwas purified chromatographically on silica gel (mobile phase: petroleum ether/ethyl acetate 4:1→2:1)